Gene linked to flu susceptibility
Some people may be at risk of a severe reaction to flu because they are not protected by a key gene, scientists have found.
Researchers have identified for the first the first time a human gene responsible for our susceptibility and response to flu and other viruses.
The answer as to why some people become seriously affected by flu and others don’t was a mystery but this study shows for the first time it may be because they are more genetically susceptible to the virus.”
The gene - IFITM3 - produces a protein that protects cells against infections.
It is thought to be critical in the immune system’s response against viruses such as Swine Flu.
The study found that patients who ended up in intensive care with potentially-fatal complications after developing flu were much more likely to have a variant of this gene.
This variant did not protect against the virus.
The research was led by the Wellcome Trust Sanger Institute working in collaboration with scientists from The Roslin Institute at the University of Edinburgh and clinicians at NHS Lothian.
The study analysed DNA from patients treated in Scottish Intensive Care Units during the 2009/10 swine flu pandemic.
Families were approached for permission to take blood samples from the patients, who had been previously fit and healthy but had developed life-threatening lung complications from flu.
Scientists found that 5.3 per cent of patients in intensive care with flu had a variant of IFITM3.
This was a significantly higher proportion of the gene variant than found in the general population, which was 0.3 per cent.
The findings strongly suggest that it plays a key role in flu susceptibility and reduced ability to fight the infection.
Genetics of influenza susceptibility in Scotland
This part of the study, called the genetics of influenza susceptibility in Scotland (GenISIS) started when the swine flu pandemic hit Scotland.
It was led by clinicians in NHS Lothian, with intensive care units across Scotland collaborating through the Scottish Critical Care Trials Group and funding from the Chief Scientists Office and the Wellcome Trust.
DNA was then extracted from these samples by researchers at The University of Edinburgh, prior to further analysis at the Sanger Institute.
The studies of patients followed initial studies at the Wellcome Trust Sanger Institute that identified the IFITM3 gene in mice.
Mice without the healthy version of the gene were much more likely to have severe symptoms than mice with the normal IFITM3 gene.
The research also involved collaboration with institutes from the United States as well as the MOSAIC consortium, which provided blood samples from flu patients in intensive care in England.
DNA samples were then analysed from 60 patients.
Flu can be devastating in the very young and elderly, but some previously fit young people can also develop life threatening lung problems.Many young people required prolonged periods in intensive care during the swine flu pandemic, and we had little idea why this small number of people was so severely affected. This study provides some clues as to why this may happen. It opens avenues for future research by clinicians and scientists to develop ways of predicting who might be at risk and where to focus efforts to find new treatments for severe viral infections.
The study is published in the journal Nature.